Feb 9, 2023 · Globus Medical and NuVasive will benefit from their respective operational advantages—including but not limited to Globus Medical’s strong, in-house manufacturing capacity and NuVasive’s global distribution networks, including NuVasive’s Memphis-based global distribution center.

Globus Medical and NuVasive have officially joined forces. We’re committed to providing innovative technologies and industry-leading clinical support to help surgeons and healthcare providers deliver better care around the globe.

Apr 27, 2023 · Globus Medical and NuVasive commenced mailing of the definitive joint proxy statement/prospectus to their respective stockholders on March 29, 2023. Globus Medical and NuVasive may also file other documents with the SEC regarding the proposed transaction.

Sep 1, 2023 · The merger between Globus Medical and NuVasive combines their complementary global scale, expanded commercial reach, comprehensive portfolios in spine and orthopedics, commitment to product...

Globus Medical and NuVasive have officially joined forces. We’re committed to providing innovative technologies and industry-leading clinical support to help surgeons and healthcare providers deliver better care around the globe.

Sep 4, 2023 · Globus Medical's (GMED) recent deal combines complementary spine and orthopedic solutions, enabling technologies to create one of the industry's most comprehensive, innovative offerings.

Globus Medical and NuVasive have officially joined forces. We’re committed to providing innovative technologies and industry-leading clinical support to help surgeons and healthcare providers deliver better care around the globe.

Feb 9, 2023 · Globus Medical Inc (NYSE: GMED) and NuVasive Inc (NASDAQ: NUVA) have agreed to combine in an all-stock transaction, bringing together two technology companies to accelerate globalization...

Sep 4, 2023 · Musculoskeletal solutions company Globus Medical has concluded the previously announced merger with spine technology company NuVasive. In February of this year, Globus Medical agreed to acquire Nuvasive in an all-stock transaction valued at approximately $3.1bn.

Feb 9, 2023 · Globus Medical said it has agreed to acquire NuVasive in an all-stock deal valued at $3.1 billion and aimed at creating the world’s “leading musculoskeletal technology company.”